1. Home
  2. MEI vs VNDA Comparison

MEI vs VNDA Comparison

Compare MEI & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methode Electronics Inc.

MEI

Methode Electronics Inc.

HOLD

Current Price

$8.46

Market Cap

312.7M

Sector

Technology

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.17

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEI
VNDA
Founded
1946
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.7M
474.0M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
MEI
VNDA
Price
$8.46
$8.17
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$9.00
$14.13
AVG Volume (30 Days)
345.5K
3.5M
Earning Date
03-05-2026
05-13-2026
Dividend Yield
2.36%
N/A
EPS Growth
49.14
N/A
EPS
N/A
N/A
Revenue
$908,300,000.00
$216,105,000.00
Revenue This Year
N/A
$26.20
Revenue Next Year
$3.66
$31.02
P/E Ratio
N/A
N/A
Revenue Growth
11.24
8.72
52 Week Low
$5.08
$3.81
52 Week High
$10.24
$9.60

Technical Indicators

Market Signals
Indicator
MEI
VNDA
Relative Strength Index (RSI) 50.21 57.63
Support Level $8.42 $4.25
Resistance Level $8.61 $8.29
Average True Range (ATR) 0.42 0.54
MACD -0.09 0.21
Stochastic Oscillator 26.72 74.26

Price Performance

Historical Comparison
MEI
VNDA

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: